Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 1
2018 1
2019 3
2020 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Analysis of brain edema in RHAPSODY.
Schleicher RL, Vorasayan P, McCabe ME, Bevers MB, Davis TP, Griffin JH, Hinduja A, Jadhav AP, Lee JM, Sawyer RN Jr, Zlokovic BV, Sheth KN, Fedler JK, Lyden P, Kimberly WT; NN104 Investigators. Schleicher RL, et al. Int J Stroke. 2024 Jan;19(1):68-75. doi: 10.1177/17474930231187268. Epub 2023 Jul 16. Int J Stroke. 2024. PMID: 37382409
Hemodynamic latency is associated with reduced intelligence across the lifespan: an fMRI DCM study of aging, cerebrovascular integrity, and cognitive ability.
Anderson AE, Diaz-Santos M, Frei S, Dang BH, Kaur P, Lyden P, Buxton R, Douglas PK, Bilder RM, Esfandiari M, Friston KJ, Nookala U, Bookheimer SY. Anderson AE, et al. Brain Struct Funct. 2020 Jul;225(6):1705-1717. doi: 10.1007/s00429-020-02083-w. Epub 2020 May 30. Brain Struct Funct. 2020. PMID: 32474754 Free PMC article.
Thrombolytic Therapy for Acute Ischemic Stroke.
Lyden PD. Lyden PD. Stroke. 2019 Sep;50(9):2597-2603. doi: 10.1161/STROKEAHA.119.025699. Epub 2019 Jul 22. Stroke. 2019. PMID: 31327316 Free PMC article. No abstract available.
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.
Lyden P, Pryor KE, Coffey CS, Cudkowicz M, Conwit R, Jadhav A, Sawyer RN Jr, Claassen J, Adeoye O, Song S, Hannon P, Rost NS, Hinduja A, Torbey M, Lee JM, Benesch C, Rippee M, Rymer M, Froehler MT, Clarke Haley E, Johnson M, Yankey J, Magee K, Qidwai J, Levy H, Mark Haacke E, Fawaz M, Davis TP, Toga AW, Griffin JH, Zlokovic BV; NeuroNEXT Clinical Trials Network NN104 Investigators. Lyden P, et al. Ann Neurol. 2019 Jan;85(1):125-136. doi: 10.1002/ana.25383. Epub 2019 Jan 7. Ann Neurol. 2019. PMID: 30450637 Free PMC article. Clinical Trial.
12 results